Table 1.
Patient-related variables: |
Age at transplant: 13-20 vs 21-30 vs 31-40 vs 41-50 vs 51-60 years |
Karnofsky performance status at transplant: ≥90% vs <90% |
Disease-related: |
Disease status and chemosensitivity at transplant: PIF-sensitive vs PIF resistant vs REL sensistive vs REL resistant vs REL untreated/unknown |
Extranodal involvement prior to transplant: yes vs no |
LDH concentration at transplant: normal vs abnormal vs unknown |
Treatment-related: |
Time from autologous to allogeneic transplant: <12 vs 12-24 vs ≥24 months |
Donor type: HLA-matched unrelated vs HLA-mismatched unrelated |
Donor-recipient gender match: F-M vs others |
Donor/Recipient CMV status: -/- vs others |
Included in all models.